The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Prevention Research"
DOI: 10.1158/1940-6207.capr-17-0091
Abstract: This clinical trial developed a personalized dosing model for reducing prostaglandin E2 (PGE2) in colonic mucosa using ω-3 fatty acid supplementation. The model utilized serum eicosapentaenoic acid (EPA, ω-3):arachidonic acid (AA, ω-6) ratios as biomarkers… read more here.
Keywords: reducing prostaglandin; pge2; fatty acid; model ... See more keywords